The lack of affordable small-scale manufacturing has been a persistent challenge for Canadian researchers, and a gap in the country’s biomedical landscape.
Organization: University of Saskatchewan
R&D funding is just one of several factors that have contributed to the success of innovation superclusters across Europe.
With the goal becoming a mainstream healthcare company, Smiths Falls, ON-based Canopy Growth Corp. has spun off a new division – Spectrum Therapeutics – to oversee the company’s commercial medical and clinical research operations including Spectrum Cannabis, Canopy Health Innovations, and recently acquired Germany-based C3Cannabinoid Compound Company, which develops cannabinoid-based medical therapies. – Canopy Growth…
Details are beginning to emerge on cuts to R&D in the April 11 Ontario budget: $1 million for the Mowat Centre (closing), the Institute for Competitiveness & Prosperity (closing) and the province’s Health System Research Fund (clawed back). R$ will investigate these and other cuts further. – Mowat Centre Canada and Japan have signed two…
Nine research teams across Canada receive CANARIE funding to develop research data management tools.
Canadian researchers whose work relies on access to a neutron beam source have issued an urgent appeal to the federal government for stop-gap funding to offset the looming impact from the March 2018 closure of the National Research Universal (NRU) reactor at Chalk River ON. The Canadian Neutron Initiative (CNI) is requesting $24 million over the next three years and $19 million a year between 2021 and 2029 to buy beam time at foreign facilities and to upgrade the small, medium-flux nuclear reactor at McMaster Univ.